DeBassio W A, Parsons R L, Schnitzler R M
Br J Pharmacol. 1976 Aug;57(4):565-71. doi: 10.1111/j.1476-5381.1976.tb10386.x.
The effects of the ionophore X-537A were studied on carbamylcholine (carbachol)-induced densitization and on tension development in relaxed potassium-depolarized frog sartorius muscles. 2 X-537A accelerated carbachol-induced desensitization in Ca2+-deficient solutions without having any effect on the conductance of the membrane in the absence of carbachol or on the extent of the carbachol-induced increase in conductance. 3 In Ca2+-deficient solution, the acceleration of desensitization by the ionophore was concentration-dependent. No effect was observed with concentrations less than 5 muM and maximal acceleration was evident with 10 muM. 4 The influence of X-537A on desensitization was time-dependent. At 20 muM X-537A, there was a marked acceleration of desensitization by the end of 5 min exposure. An additional gradual acceleration occurred during a 5 to 30 min treatment. No acceleration of desensitization was evident when X-537A was simultaneously applied with carbachol to the end-plate region without prior exposure to the ionophore. 5 Desensitization also was accelerated by 30 min exposure to 20 muM X-537A in solutions containing Ca2+ or deficient in both Mg2+ and Ca2+; the rate being increased 2.8-fold in Ca2+-containing solutions, 2.9-fold in Ca2+-deficient solutions containing Mg2+, and 2.5-fold in divalent cation-deficient solutions. 6 Tension development gradually occurred in relaxed potassium-depolarized muscle preparations exposed to 20 muM X-537A. The onset of tension development occurred only after approximately 25 min of exposure both in preparations kept in Ca2+-deficient or Ca2+-containing solutions. By the end of 90 min in the ionophore, the tension developed was approximately 12% and 23% of the initial potassium contracture in those preparations maintained in the Ca2+-deficient or Ca2+-containing solutions, respectively. 7 We assume that the increase in desensitization rate following exposure to X-537A results from an elevation of the intracellular Ca2+ concentration. That muscle tension gradually increased during exposure to the ionophore supports this conclusion. The acceleration of densitization by X-537A in the absence of external Ca2+ supports the view that the site of calcium acceleration is not on the external surface of the end-plate membrane either at or near the agonist-recognition site but rather on the inner surface.
研究了离子载体X - 537A对氨甲酰胆碱(卡巴胆碱)诱导的脱敏作用以及对松弛的钾去极化青蛙缝匠肌张力发展的影响。2 X - 537A在缺钙溶液中加速了卡巴胆碱诱导的脱敏作用,而对无卡巴胆碱时膜的电导或卡巴胆碱诱导的电导增加程度没有任何影响。3在缺钙溶液中,离子载体对脱敏的加速作用呈浓度依赖性。浓度低于5μM时未观察到作用,10μM时脱敏加速作用最为明显。4 X - 537A对脱敏的影响是时间依赖性的。在20μM X - 537A时,暴露5分钟结束时脱敏明显加速。在5至30分钟的处理过程中,脱敏进一步逐渐加速。当X - 537A与卡巴胆碱同时应用于终板区域而未事先暴露于该离子载体时,未观察到脱敏加速。5在含有Ca2 +或同时缺乏Mg2 +和Ca2 +的溶液中,暴露于20μM X - 537A 30分钟也会加速脱敏;在含Ca2 +的溶液中速率增加2.8倍,在含Mg2 +的缺钙溶液中增加2.9倍,在缺乏二价阳离子的溶液中增加2.5倍。6在暴露于20μM X - 537A的松弛钾去极化肌肉标本中,张力逐渐发展。无论是保存在缺钙还是含Ca2 +溶液中的标本,张力发展的起始都仅在暴露约25分钟后出现。在离子载体作用90分钟结束时,在缺钙或含Ca2 +溶液中保存的标本中,所产生的张力分别约为初始钾挛缩的12%和23%。7我们假设,暴露于X - 537A后脱敏速率的增加是由于细胞内Ca2 +浓度升高所致。在暴露于离子载体期间肌肉张力逐渐增加支持了这一结论。X - 537A在无细胞外Ca2 +时对脱敏的加速作用支持了这样一种观点,即钙加速的位点不在终板膜的外表面,无论是在激动剂识别位点处还是附近,而是在内表面。